title: Primary signet-ring cell adenocarcinoma of the uterine cervix: case report and review of the literature.
abstract: Signet-ring cell adenocarcinoma is a rare subtype of the uterine cervix; thus there are no guidelines and the prognosis is unknown. There seems to be a significant role for reporting the treatment and outcome of this rare disease in order to establish guidelines and to assist in decision-making. However, treatment should be tailored to each patient according to clinical status and disease stage. Excluding extra-genital origin is mandatory, as it will change treatment management considerably.
authors.affiliation: Division of Oncology, Rambam Health Care Campus, Haifa, Israel.
authors.forename: O
authors.initials: O
authors.lastname: Kaidar-Person
authors.forename: A
authors.initials: A
authors.lastname: Amit
authors.forename: A
authors.initials: A
authors.lastname: Berniger
authors.forename: R
authors.initials: R
authors.lastname: Ben-Yosef
authors.forename: A
authors.initials: A
authors.lastname: Kuten
authors.forename: R
authors.initials: R
authors.lastname: Bortnyak-Abdah
mesh_terms: D000230:Adenocarcinoma / Q000000981:diagnostic imaging / Q000473:pathology*; D000328:Adult; D018279:Carcinoma, Signet Ring Cell / Q000000981:diagnostic imaging / Q000473:pathology*; D005260:Female; D006801:Humans; D064847:Multimodal Imaging; D009367:Neoplasm Staging; D049268:Positron-Emission Tomography; D014057:Tomography, X-Ray Computed; D002583:Uterine Cervical Neoplasms / Q000000981:diagnostic imaging / Q000473:pathology*